Literature DB >> 10091675

Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis.

M H Chen1, M G Steiner, S E de Laszlo, A A Patchett, M S Anderson, S A Hyland, H R Onishi, L L Silver, C R Raetz.   

Abstract

A series of carbohydroxamido-oxazolidine inhibitors of UDP-3-O-[R-3-hydroxymyristoyl]-GlcNAc deacetylase, the enzyme responsible for the second step in lipid A biosynthesis, was identified. The most potent analog L-161,240 showed an IC50 = 30 nM in the DEACET assay and displayed an MIC of 1-3 microg/mL against wild-type E. coli.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091675     DOI: 10.1016/s0960-894x(98)00749-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.

Authors:  Douglas A Whittington; Kristin M Rusche; Hyunshun Shin; Carol A Fierke; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-20       Impact factor: 11.205

2.  Antimicrobial activity of CHIR-090, an inhibitor of lipopolysaccharide biosynthesis, against the Burkholderia cepacia complex.

Authors:  Karin Bodewits; Christian R H Raetz; John R Govan; Dominic J Campopiano
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

3.  Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa.

Authors:  Khisimuzi E Mdluli; Pamela R Witte; Toni Kline; Adam W Barb; Alice L Erwin; Bryce E Mansfield; Amanda L McClerren; Michael C Pirrung; L Nathan Tumey; Paul Warrener; Christian R H Raetz; C Kendall Stover
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 4.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

5.  Structural basis of the promiscuous inhibitor susceptibility of Escherichia coli LpxC.

Authors:  Chul-Jin Lee; Xiaofei Liang; Ramesh Gopalaswamy; Javaria Najeeb; Eugene D Ark; Eric J Toone; Pei Zhou
Journal:  ACS Chem Biol       Date:  2013-10-31       Impact factor: 5.100

6.  FtsH-mediated coordination of lipopolysaccharide biosynthesis in Escherichia coli correlates with the growth rate and the alarmone (p)ppGpp.

Authors:  Michael Schäkermann; Sina Langklotz; Franz Narberhaus
Journal:  J Bacteriol       Date:  2013-02-15       Impact factor: 3.490

Review 7.  Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.

Authors:  Alice L Erwin
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

8.  Control of lipopolysaccharide biosynthesis by FtsH-mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria.

Authors:  Sina Langklotz; Michael Schäkermann; Franz Narberhaus
Journal:  J Bacteriol       Date:  2010-12-30       Impact factor: 3.490

9.  Antibacterial activities and characterization of novel inhibitors of LpxC.

Authors:  John M Clements; Fanny Coignard; Ian Johnson; Stephen Chandler; Shilpa Palan; Andrew Waller; Jac Wijkmans; Michael G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

10.  A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.

Authors:  Nicola L Ramsden; Lori Buetow; Alice Dawson; Lauris A Kemp; Venkatsubramanian Ulaganathan; Ruth Brenk; Gerhard Klebe; William N Hunter
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.